Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1563400 | 0.82 | NR1I2 (0.51) | MAPTALDH1A1 | |
| SCHEMBL4609480 | 0.81 | HTT (0.40) | CYP2C9CYP2C19MAPTALDH1A1 | |
| SCHEMBL4611213 | 0.81 | TSHR (0.55) | SRCNPC1MAPTALDH1A1TSHR | |
| SCHEMBL4610697 | 0.80 | FAAH (0.47) | TSHR | |
| SCHEMBL4610119 | 0.78 | ALDH1A1 (0.44) | CYP2C9CYP2C19SRCATMTDP1 | |
| SCHEMBL4612087 | 0.78 | CYP3A4 (0.42) | ATML3MBTL1NPC1ALDH1A1TSHR | |
| SCHEMBL18177963 | 0.78 | FAAH (0.51) | ALDH1A1TSHR | |
| Phenyl Diphenoxyphosphinecarboxylate Oxide SCHEMBL4610556 | 0.77 | SRC (0.54) | CYP2C9CYP2C19SRCATMTDP1 | |
| Phenyl Dimethoxyphosphinecarboxylate Oxide SCHEMBL4610736 | 0.76 | SRC (0.42) | CYP2C9CYP2C19SRCATMTDP1 | |
| SCHEMBL18182328 | 0.73 | NPC1 (0.47) | CYP2C9CYP2C19L3MBTL1NPC1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10374256-B2 | Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same | UBE INDUSTRIES, LTD. (JP) | 2019-08-06 | — | — | US | disclosed |
| US-20160315351-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHONOFORMIC ACID COMPOUND USED IN SAME | UBE INDUSTRIES, LTD (JP) | 2016-10-27 | — | — | US | disclosed |
| US-20160315351-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHONOFORMIC ACID COMPOUND USED IN SAME | UBE INDUSTRIES, LTD (JP) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10374256-B2 | Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same | HCN2, PHOSPHO1, HCN1 | CYP2C9 3091/4885CYP2C19 3257/4885SRC 1710/4885 |
| US-20160315351-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHONOFORMIC ACID COMPOUND USED IN SAME | HCN2, PHOSPHO1, HCN1 | CYP2C9 3091/4885CYP2C19 3257/4885SRC 1710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.